Compare QUCY & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QUCY | MNTS |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Germany | United States |
| Employees | 13 | 123 |
| Industry | | Military/Government/Technical |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 6.9M |
| IPO Year | 2021 | N/A |
| Metric | QUCY | MNTS |
|---|---|---|
| Price | $0.51 | $6.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 346.5K | ★ 3.3M |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.34 | N/A |
| Revenue Next Year | $171.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.44 |
| 52 Week High | $0.74 | $15.98 |
| Indicator | QUCY | MNTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 59.84 |
| Support Level | $0.43 | $4.82 |
| Resistance Level | $0.53 | $8.22 |
| Average True Range (ATR) | 0.07 | 1.22 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 28.54 | 57.97 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.